Multimodality treatment for hormone-naïve metastatic prostate cancer
Radiation to the primary tumour in metastatic disease: When and whom
Date
09 Oct 2016Session
Multimodality treatment for hormone-naïve metastatic prostate cancerPresenters
Alberto BossiAuthors
A. BossiAuthor affiliations
- Radiotherapy, Gustave Roussy, Paris/FR
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Docetaxel for prostate cancer: Best timing and right patient
Presenter: Nick James
Session: Multimodality treatment for hormone-naïve metastatic prostate cancer
Resources:
Slides
Webcast
Does radical prostatectomy have an impact on long-term outcomes of patients with metastatic prostate cancer?
Presenter: Axel Heidenreich
Session: Multimodality treatment for hormone-naïve metastatic prostate cancer
Resources:
Slides
Webcast